{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:26:21Z","timestamp":1773282381680,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-012-0505-5","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T07:58:57Z","timestamp":1354175937000},"page":"456-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis"],"prefix":"10.1016","volume":"19","author":[{"given":"Koichi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Muratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-012-0505-5_bib0005","first-page":"S61","article-title":"Oral ceftibuten switch therapy for acute pyelonephritis in children","volume":"84","author":"Vilaichone","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1007\/s10156-012-0505-5_bib0010","first-page":"183","article-title":"Prospective, randomized, controlled study comparing two dosing regimens of gentamicin\/oral ciprofloxacin switch therapy for acute pyelonephritis","volume":"46","author":"Bailey","year":"1996","journal-title":"Clin Nephrol"},{"issue":"5A","key":"10.1007\/s10156-012-0505-5_bib0015","doi-asserted-by":"crossref","first-page":"157S","DOI":"10.1016\/0002-9343(89)90048-X","article-title":"Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections","volume":"87","author":"Cox","year":"1989","journal-title":"Am J Med"},{"key":"10.1007\/s10156-012-0505-5_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s101560200001","article-title":"Clinical assessment of tosufloxacin tosilate","volume":"8","author":"Kohno","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0025","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5","year":"2003"},{"key":"10.1007\/s10156-012-0505-5_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/emj.19.1.19","article-title":"Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomized controlled trial","volume":"19","author":"Sanchez","year":"2002","journal-title":"Emerg Med J"},{"key":"10.1007\/s10156-012-0505-5_bib0035","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.46.9.2895-2900.2002","article-title":"Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study","volume":"46","author":"Tomera","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-4295(02)01664-3","article-title":"A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults","volume":"60","author":"Jimenez-Cruz","year":"2002","journal-title":"Urology"},{"issue":"suppl 2","key":"10.1007\/s10156-012-0505-5_bib0045","first-page":"ii67","article-title":"Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","volume":"53","author":"Wells","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7\u00a0days) and trimethoprim\u2013sulfamethoxazole (14\u00a0days) for acute uncomplicated pyelonephritis in women: a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1007\/s10156-012-0505-5_bib0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s101560170023","article-title":"Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis","volume":"7","author":"Takahashi","year":"2001","journal-title":"J Infect Chemother"},{"issue":"S-1","key":"10.1007\/s10156-012-0505-5_bib0060","first-page":"141","article-title":"Phase I clinical study of pazufloxacin mesilate","volume":"47","author":"Nakashima","year":"1999","journal-title":"Jpn J Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s101560200000","article-title":"Pharmacokinetics and safety assessments of tosufloxacin tosilate","volume":"8","author":"Niki","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0070","first-page":"649","article-title":"Comparative study of T-3262 (tosufloxacin tosilate 9) and norfloxacin in complicated urinary tract infections","volume":"37","author":"Kawada","year":"1989","journal-title":"Chemotherapy"},{"issue":"suppl 1","key":"10.1007\/s10156-012-0505-5_bib0075","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/clind\/15.Supplement_1.S216","article-title":"Evaluation of new anti-infective drugs for the treatment of urinary tract infection","volume":"15","author":"Rubin","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1007\/s10156-012-0505-5_bib0080","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijantimicag.2004.02.001","article-title":"Bacterial resistance to antimicrobials in urinary isolates","volume":"24","author":"Muratani","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-012-0505-5_bib0085","first-page":"263","article-title":"Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007","volume":"63","author":"Wada","year":"2009","journal-title":"Acta Med Okayama"},{"key":"10.1007\/s10156-012-0505-5_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10156-010-0174-1","article-title":"The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy","volume":"17","author":"Ishikawa","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-012-0505-5_bib0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10156-009-0721-9","article-title":"Efficacy of treatment with carbapenems and third-generation cephalosporins for patients with febrile complicated pyelonephritis","volume":"15","author":"Takahashi","year":"2009","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-012-0505-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:49:44Z","timestamp":1761158984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13701284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13701284"],"URL":"https:\/\/doi.org\/10.1007\/s10156-012-0505-5","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-012-0505-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}